Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Cancer With Central Nervous System Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07304739
What this trial is testing

Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05379803
What this trial is testing

High-dose Furmonertinib for First-line Treatment of EGFR Mutated NSCLC With Central Nervous System (CNS) Metastases

Who this might be right for
Non-Small Cell Lung Cancer
Hunan Province Tumor Hospital 40
Not applicableWithdrawnNCT01731704
What this trial is testing

Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases

Who this might be right for
Brain Metastases
University of California, San Francisco
Early research (Phase 1)Looking for participantsNCT06253871
What this trial is testing

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Who this might be right for
HER2 Mutation-Related TumorsHER2HER2-positive Breast Cancer+10 more
Iambic Therapeutics, Inc 383
Testing effectiveness (Phase 2)Study completedNCT00312728
What this trial is testing

Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT)

Who this might be right for
Non-Small Cell Lung CancerBrain Neoplasms
Genentech, Inc. 115
Testing effectiveness (Phase 2)UnknownNCT02655536
What this trial is testing

Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial

Who this might be right for
Carcinoma, Non-Small-Cell LungBrain Neoplasms
National Taiwan University Hospital 109
Testing effectiveness (Phase 2)Study completedNCT02107755
What this trial is testing

Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma

Who this might be right for
Liver MetastasesLung MetastasesRecurrent Melanoma+2 more
Ohio State University Comprehensive Cancer Center 8
Testing effectiveness (Phase 2)Ended earlyNCT00872482
What this trial is testing

Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases

Who this might be right for
Metastatic Non-Small Cell Lung Cancer
YM BioSciences 21
Not applicableStudy completedNCT07646041
What this trial is testing

Annual Brain MRI Surveillance for Detection of Brain Metastasis in Patients With Lung Cancer

Who this might be right for
Lung CancerBrain MetastasasesMRI+1 more
Samsung Medical Center 229,323
Large-scale testing (Phase 3)UnknownNCT01158170
What this trial is testing

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

Who this might be right for
Non-small Cell Lung Cancer
Zhejiang Cancer Hospital 200
Early research (Phase 1)Ended earlyNCT05241873
What this trial is testing

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

Who this might be right for
Lung Neoplasm MalignantCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms+17 more
Blueprint Medicines Corporation 103
Large-scale testing (Phase 3)UnknownNCT04058704
What this trial is testing

Determine the Efficiency For Brain Metastasis NSCLC Patients Treated With Icotinib Alone or Combined With Radiation Therapy

Who this might be right for
Non Small Cell Lung CancerBrain Metastases
Betta Pharmaceuticals Co., Ltd. 296
Early research (Phase 1)Study completedNCT00539383
What this trial is testing

A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer

Who this might be right for
Advanced Solid Tumors With and Without Brain Metastases
Angiochem Inc 56
Not applicableUnknownNCT02607605
What this trial is testing

A Prospective, Observational Trial on the Diagnostic and Prognostic of LM

Who this might be right for
Lung NeoplasmsMeningeal Carcinomatosis
Sun Yat-sen University 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07197008
What this trial is testing

Sacituzumab Tirumotecan (Sac-TMT) Plus Bevacizumab in 3rd Generation EGFR-TKI Treated Advanced EGFR-mutant Nonsquamous NSCLC With Brain Metastasis

Who this might be right for
Lung Cancer
Li-kun Chen 50
Post-approval studies (Phase 4)UnknownNCT05748093
What this trial is testing

Improving Osimertinib Exposure and Cost-effectiveness Using Pharmacokinetic Boosting With Cobicistat

Who this might be right for
Non-small Cell Lung Cancer
Maastricht University Medical Center 60
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Not applicableLooking for participantsNCT07143045
What this trial is testing

A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases

Who this might be right for
EGFR Mutant Advanced Non-small Cell Lung CancerCentral Nervous System (CNS) Metastases
Alpha Biopharma (Jiangsu) Co., Ltd. 800
Not applicableLooking for participantsNCT06718972
What this trial is testing

A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China

Who this might be right for
Meningeal MetastasisNon-Small Cell Lung Cancer
Guangzhou Medical University 1,000
Testing effectiveness (Phase 2)Study completedNCT00372775
What this trial is testing

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Who this might be right for
Non-Small Cell Lung Cancer
Pfizer 66
Next Page